Press releases

Taichung Veterans General Hospital selects RayStation

RaySearch Laboratories AB (publ) announces that SHI Industrial Equipment (Taiwan) Co., Ltd. (SIET) has placed an order for RayStation®* treatment planning system to be installed at Taichung Veterans General Hospital (TCVGH), Taichung, Taiwan. SIET is a subsidiary of Sumitomo Heavy Industries, Ltd. which is a proton therapy machine vendor.

The order includes licenses for both proton and photon treatment as well as advanced functionality such as Multi Criteria Optimization (MCO) and dose calculation on CBCT images for proton treatment.

TCVGH will use a Sumitomo proton therapy machine with Sumitomo's compact next-generation system, to which RayStation will be adapted, enabling TCVGH to utilize the new system's method for very fast delivery of treatment plans for the treatment of moving tumors.

Dr. Weir Chiang You, Chief of the Department of Radiation Oncology at Taichung Veterans General Hospital (TCVGH), says: “I am delighted to announce that TCVGH will soon be incorporating the state-of-the-art Sumitomo proton therapy machine into our clinical practice. Recognized as a global leader in the development of advanced software for proton therapy treatment planning, RaySearch's innovative approach and commitment to improving cancer treatment align perfectly with our mission at TCVGH. Their premier product, RayStation, will provide our medical professionals with the tools they need to optimize patient treatment plans and improve therapy outcomes.”

Johan Löf, founder and CEO, RaySearch, says: “The strong demand for RayStation from proton therapy clinics continues and I am pleased that we can support Sumitomo’s compact system, making this technology available in an optimal way to cancer patients in the region. RaySearch has always had the ambition to support all available machines on the market.”

The order value is approximately MEUR 1.9 (corresponding to approximately MSEK 21), excluding service contract, and was received in Q2, 2023. Delivery is planned for 2025 and is expected to generate revenue from then and onwards.

Taichung Veterans General Hospital (TCVGH) was founded in 1982. Since 1991 it has been accredited “Medical Center and First Class Teaching Hospital” by the governmental Department of Health. TCVGH is a 1,624-bed hospital with around 4,250 employees.  About 7,700 outpatients and 160 patients are treated in the emergency room daily. As a public medical center, TCVGH provides safe, high-quality medical services with advanced facilities and training programs as well as outstanding research and development programs.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.  

RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at

About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.

* Subject to regulatory clearance in some markets.

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00